Healthcare >> CEO Interviews >> March 24, 2003

Frank Massino – Senetek Plc (sntk)

FRANK MASSINO has been Chairman and CEO of Senetek PLC since November 1998. Drawing on his professional management experience at major corporations such as Glaxo, Ortho Pharmaceutical Corporation, Johnson & Johnson, Pfizer, and IBM, Mr. Massino has reshaped the corporate structure of Senetek, defined its strategic direction, and focused the company soundly on its core competencies. During his career, Mr. Massino has successfully negotiated more than 40 licensing agreements with major pharmaceutical companies. For nine years he held executive management positions at Ortho Pharmaceutical, including Director of Business Development and New Products, and in 1982, was named 'Division Manager of the Year.' While at Ortho, he was Product Manager for Retin-A, a leading prescription product for the treatment of acne. In addition, Mr. Massino was involved in the development of Renova', which in 1995, was also approved for anti-aging applications under the Renova trademark, and directed major product launches for the company. As Product Director of Marketing and Division Sales Manager at Glaxo Inc., he re- positioned a mature line of corticosteroids into a $50 million psoriasis business, successfully launched two new ethical pharmaceutical products, and championed the internal development of two critically important product line extensions. Mr. Massino holds a degree in Finance and Chemistry from the University of Illinois and is a graduate of the Marketing Management Program of the Columbia Executive Program at Columbia University and the Management of Managers Program of the Graduate School of Business Administration at the University of Michigan. Mr. Massino is highly experienced in drug delivery technology and holds a patent on a drug delivery device. He is an active member of the Licensing Executive Society. Profile
TWST: Could you give us an overview of what Senetek does?

Mr. Massino: Senetek is a healthcare technology company that

focuses on the development and distribution of proprietary

products that